午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Hubei Moxin Biotechnology Co., Ltd

Hubei Moxin Biotechnology Co., Ltd

Main products: Drug standards,Drug intermediates,Drug impurity reference,Peptide customization

mike
Current Location: HOME >> Product
Product Categories
Moxin Chemicals
Country: China
Tel:
Mobile: 17320513646
E-mail: mike@molcoo.com
QQ: 3001071511
Skype: Chat Now!
Address: Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
Product Name MF CAS Details
[Thr6]-Bradykinin C51H75N15O11 6120-63-4 Details
[Sar1,Ala8]-Angiotensin II C43H67N13O10 38027-95-1 Details
Bradykinin (1-7) C35H52N10O9 23815-87-4 Details
Tyr-Bradykinin C50H73N15O12 32222-00-7 Details
Bradykinin [Hyp3] C50H73N15O12 37642-65-2 Details
Angiotensin II human C50H71N13O12 4474-91-3 Details
Apelin-13 (human, bovine, mouse, rat) C69H111N23O16S 217082-58-1 Details
Atriopeptin I (rat) C83H135N29O30S2 89139-53-7 Details
Angiotensinogen (1-14), Porcine C85H123N21O20 20845-02-7 Details
LL-37 FKR C118H199N37O30 913736-94-4 Details
[Pyr1] - Apelin-13 C69H108N22O16S 217082-60-5 Details
Tachyplesin I C99H151N35O19S4 118231-04-2 Details
Magainin I C112H177N29O28S 108433-99-4 Details
Antho-Rfamide C22H32N8O5 107535-01-3 Details
[Sar1,Thr8]-Angiotensin II C44H69N13O11 53632-49-8 Details
Polybia-MP1 C78H132N20O19 872043-01-1 Details
BNP-45 ,rat C213H349N71O65S3 123337-89-3 Details
Calcitonin (8-32) (salmon I) C119H198N36O37 155069-90-2 Details
Angiotensin I/II (1-6) C36H55N11O10 47896-63-9 Details
Apelin-36 (human) C184H295N69O42R2S 252642-12-9 Details
Bradykinin [Des-Arg9] C44H61N11O10 15958-92-6 Details
Lactoferricin B25 C141H224N46O29S3 146897-68-9 Details
Calcitonin, salmon C145H240N44O48S2 47931-85-1 Details
Bradykinin C50H73N15O11 58-82-2 Details
[Val4]-Angiotensin III C45H64N12O9 100900-28-5 Details
Calcitonin, porcine C159H232N46O45S3 12321-44-7 Details
Met-Lys-Bradykinin C61H94N18O13S 550-19-6 Details
LL-37 (scrambled) 1354065-56-7 Details
α-Synuclein (67-78) (human) trifluoroacetate salt C43H76N12O15 2243206-99-5 Details
Bradykinin (1-3) C16H28N6O4 23815-91-0 Details
Pseudin-2 C122H202N36O32 388602-02-6 Details
Lys-Bradykinin-Ser-Val-Gln-Val-Ser C57H89N19O13 135701-67-6 Details
BNP-32, rat C146H239N47O44S3 133448-20-1 Details
Angiotensin I/II (3-7) C31H45N7O7 122483-84-5 Details
[D-Phe7]-Bradykinin C54H75N15O11 97825-00-8 Details
CTX IV (6-12) C48H70N10O7 115722-23-1 Details
Magainin II C114H180N30O29S 108433-95-0 Details
Angiotensin II Antipeptide C42H62N10O12 121379-63-3 Details
Atriopeptin III (rat) C107H165N35O34S2 90817-13-3 Details
Apelin-12 (human, bovine, mouse, rat) C64H103N21O14S 229961-08-4 Details
Calcitonin N-Terminal Flanking Peptide, human; N – Procalcitonin C264H426N74O97S 118277-01-3 Details
[Sar1,Gly8]-Angiotensin II C44H69N13O12 100900-29-6 Details
Lys-(Ala3)-Bradykinin C54H83N17O12 103545-18-2 Details
Angiotensinogen (1-14), human C83H122N24O19 104180-23-6 Details
Sapecin C164H272N58O52S6 119938-54-4 Details
Lactoferricin B (4-14) (bovine) C70H113N25O13S 183476-25-7 Details
Atriopeptin II (rat, rabbit, mouse) C141H227N51O42S2 98084-69-6 Details
Seminalplasmin Fragment (SPF) Analog C76H123N17O16 147958-06-3 Details
APL1β25 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-25) C98H166N28O35S 1233876-43-1 Details
APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28) C109H185N31O39S 1233876-42-0 Details
Annexin A1 (1-25) (dephosphorylated) (human) C141H210N32O44S 151988-33-9 Details
Calcitonin, rat C148H228N40O46S3 11118-25-5 Details
Angiotensin (1-5) C30H48N8O9 58442-64-1 Details
Calcitonin Gene Related Peptide, rat C162H262N50O52S2 96827-03-1 Details
Angiotensinogen (1-14) ,Rat C89H123N21O21 110200-37-8 Details
α-Synuclein (61-95) (human) trifluoroacetate salt/NAC, α-Synuclein (61-95) (human) C141H235N39O49 154040-19-4 Details
Angiotensin 1 Human C62H89N17O14 484-42-4 Details
α-Synuclein (71-82) (human) trifluoroacetate salt C51H92N14O17 332867-16-0 Details
α-Synuclein (34-45) (human) trifluoroacetate salt C59H101N15O18 2170181-52-7 Details
Lysozyme C (46-61) (chicken) C72H116N22O29 62982-31-4 Details
Antho-Rwamide II C30H44N10O6 118904-15-7 Details
[Tyr0]-Atriopeptin II (rat) C107H165N35O34S2 117856-13-0 Details
Bradykinin (1-6) C30H45N9O8 23815-88-5 Details
Antho-Rwamide I C31H46N10O7 114056-25-6 Details
IDR-1 C65H118N18O15 940291-10-1 Details
Angiotensin A C56H78N16O13 34273-12-6 Details
Ac-Angiotensinogen (1-14), porcine C87H125N21O21 66641-26-7 Details
Angiotensin II [Sar1 Ile8] C46H73N13O10 67724-27-0 Details
DCD-1L (human) C210H359N57O71 478898-18-9 Details
α-Synuclein Binding?Peptide?trifluoroacetate salt C45H80N14O14 2243207-00-1 Details
Angiotensin I/II (5-8) C26H36N6O5 34233-50-6 Details
[D-Arg0,Hyp3,D-Phe7]-Bradykinin C60H87N19O13 109333-26-8 Details
Lys-(Hyp3)-Bradykinin C56H85N17O13 113662-39-8 Details
Ranalexin C97H167N23O22S3 155761-99-2 Details
Epinecidin-1 C114H176N30O21S 1131706-77-8 Details
APL1β27 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-27) C103H174N30O38S 1233876-44-2 Details
[Sar1,Ile4,8]-Angiotensin II C43H75N13O9 185461-45-4 Details
Angiotensin III, human C46H66N12O9 12687-51-3 Details
Angiotensin I-Converting Enzyme Substrate C24H27N3O5 69677-91-4 Details
LL-37 (37-1) 2022972-70-7 Details
LL-37 FK-13 C80H135N25O17 717919-68-1 Details
[Sar1] Angiotensin II C51H75N13O12 102029-89-0 Details
Ac-Angiotensinogen (1-14), human C85H124N24O20 104180-27-0 Details
Angiotensin I/II (3-8) C40H54N8O8 23025-68-5 Details
[D-Arg0,Hyp2,3,D-Phe7]-Bradykinin C60H87N19O14 111929-26-1 Details
Bradykinin (1-5) C27H40N8O6 23815-89-6 Details
Apelin-17 (human, bovine, mouse, rat) C96H156N34O20S 217082-57-0 Details
EcAMP3 2243219-65-8 Details
Calcitonin Gene Related Peptide, chicken 104364-57-0 Details
BNP-32 ,porcine C149H250N52O44S3 117345-87-6 Details
Calcitonin, human C151H226N40O45S3 21215-62-3 Details
Extracellular Death Factor C27H36N10O10 960129-66-2 Details
Bradykinin (2-7) C29H40N6O8 23828-06-0 Details
Annexin 1 (ANXA - 1; Ac 2 - 12) C63H94N14O17S 256447-08-2 Details
[Sar1]-Angiotensin I/II (1-7) amide C40H63N13O8 126112-22-9 Details
Antioxidant peptide A C31H54N12O7S2 159147-88-3 Details
[Tyr0]-Apelin-13 (human, bovine, mouse, rat) C78H120N24O18S 1815617-96-9 Details
Lys-(Des-Arg9,Leu8)-Bradykinin C47H75N13O11 71800-37-8 Details
α-Defensin-3 (human) C151H222N44O40S6 136661-76-2 Details
LL-37 RKS 672345-61-8 Details
Product Total: Product Page:
64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99